Advisor Group Holdings, Inc. Cel Sci Corp Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Cel Sci Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 432,127 shares of CVM stock, worth $259,276. This represents 0.0% of its overall portfolio holdings.

Number of Shares

432,127

Previous 447,673 3.47%

Holding current value

$259,276

Previous $519,000 11.75%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.05 - $1.5 $16,323 - $23,319	-15,546 Reduced 3.47%	432,127 $458,000
Q2 2024 Aug 13, 2024	BUY	$1.11 - $1.85 $154,839 - $258,065	139,495 Added 45.26%	447,673 $519,000
Q1 2024 May 10, 2024	SELL	$1.63 - $3.08 $91,795 - $173,453	-56,316 Reduced 15.45%	308,178 $588,000
Q4 2023 Feb 12, 2024	SELL	$1.07 - $3.07 $399,524 - $1.15 Million	-373,387 Reduced 50.6%	364,494 $991,000
Q3 2023 Nov 13, 2023	BUY	$1.17 - $2.86 $411,679 - $1.01 Million	351,863 Added 91.15%	737,881 $922,000
Q2 2023 Aug 10, 2023	BUY	$2.11 - $2.83 $14,348 - $19,244	6,800 Added 1.79%	386,018 $930,000
Q1 2023 May 12, 2023	BUY	$2.17 - $3.13 $781 - $1,126	360 Added 0.1%	379,218 $879,000
Q4 2022 Feb 10, 2023	BUY	$1.99 - $3.52 $42,703 - $75,535	21,459 Added 6.0%	378,858 $890,000
Q3 2022 Nov 14, 2022	BUY	$3.09 - $5.23 $3,794 - $6,422	1,228 Added 0.34%	357,399 $1.1 Million
Q2 2022 Aug 10, 2022	BUY	$2.58 - $4.99 $122,777 - $237,464	47,588 Added 15.42%	356,171 $1.6 Million
Q1 2022 May 04, 2022	BUY	$3.93 - $7.7 $681,194 - $1.33 Million	173,332 Added 128.16%	308,583 $1.5 Million
Q3 2021 Nov 05, 2021	BUY	$7.64 - $12.49 $53,686 - $87,767	7,027 Added 5.48%	135,251 $1.49 Million
Q2 2021 Aug 02, 2021	BUY	$8.68 - $27.49 $88,049 - $278,858	10,144 Added 8.59%	128,224 $1.11 Million
Q1 2021 May 13, 2021	BUY	$12.0 - $27.64 $124,032 - $285,687	10,336 Added 9.59%	118,080 $1.8 Million
Q4 2020 Feb 10, 2021	BUY	$11.05 - $16.62 $174,545 - $262,529	15,796 Added 17.18%	107,744 $1.26 Million
Q3 2020 Nov 12, 2020	BUY	$11.69 - $14.54 $130,390 - $162,179	11,154 Added 13.81%	91,948 $1.17 Million
Q2 2020 Aug 14, 2020	BUY	$9.75 - $17.6 $264,312 - $477,118	27,109 Added 50.5%	80,794 $1.21 Million
Q1 2020 May 18, 2020	BUY	$7.54 - $17.05 $404,784 - $915,329	53,685 New	53,685 $620,000

Others Institutions Holding CVM

# of Institutions

Shares Held

Call Options Held

27.1K

Put Options Held

150K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Cel Sci Corp Transaction History